[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

JPS5655397A - Aminobenzoic acid ester derivative, and physiologically active agent containing said derivative - Google Patents

Aminobenzoic acid ester derivative, and physiologically active agent containing said derivative

Info

Publication number
JPS5655397A
JPS5655397A JP13225979A JP13225979A JPS5655397A JP S5655397 A JPS5655397 A JP S5655397A JP 13225979 A JP13225979 A JP 13225979A JP 13225979 A JP13225979 A JP 13225979A JP S5655397 A JPS5655397 A JP S5655397A
Authority
JP
Japan
Prior art keywords
aminobenzoic acid
derivative
suppressing
acid ester
active agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP13225979A
Other languages
Japanese (ja)
Other versions
JPS5938960B2 (en
Inventor
Chikao Yoshikumi
Fumio Hirose
Yoshio Omura
Takami Fujii
Masanori Ubusawa
Minoru Ohara
Kenichi Matsunaga
Takao Ando
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kureha Corp
Original Assignee
Kureha Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kureha Corp filed Critical Kureha Corp
Priority to JP54132259A priority Critical patent/JPS5938960B2/en
Priority to GB8032272A priority patent/GB2060636B/en
Priority to DE3038304A priority patent/DE3038304C2/en
Priority to BE0/202404A priority patent/BE885631A/en
Publication of JPS5655397A publication Critical patent/JPS5655397A/en
Publication of JPS5938960B2 publication Critical patent/JPS5938960B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

NEW MATERIAL:The titled compound of formula (R1 is residue of saccharide selected from arabinose, xylose, mannose, glucose, galactose, and rhamnose; R2 is methyl, ethyl, propyl or butyl; excluding o-aminobenzoic acid methyl ester-N-D- mannoside).
EXAMPLE: o-Aminobenzoic acid methyl ester-N-D-xyloside.
USE: Medicine having blood sugar level suppressing, hypotensive, blood lipid suppressing, antineoplasmic, central nervous system suppressing, and antiphlogistic activities. Since it has low toxicity and no antibacterial activity, it can be administered for a long period without the danger of teratogenecity, allergic reaction, etc. Preferably administered orally.
PROCESS: The compound of formula is prepared by reacting an aminobenzoic acid ester with a saccharide in the presence of ammonium chloride, etc., in a solvent.
COPYRIGHT: (C)1981,JPO&Japio
JP54132259A 1979-10-12 1979-10-12 Aminobenzoic acid ester derivatives and pharmaceuticals containing the derivatives Expired JPS5938960B2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP54132259A JPS5938960B2 (en) 1979-10-12 1979-10-12 Aminobenzoic acid ester derivatives and pharmaceuticals containing the derivatives
GB8032272A GB2060636B (en) 1979-10-12 1980-10-07 Esters of aminobenzoic acid their preparation and compositions containing them
DE3038304A DE3038304C2 (en) 1979-10-12 1980-10-10 N-glycosides of esters of o-, m- and p-aminobenzoic acid and medicaments containing these compounds
BE0/202404A BE885631A (en) 1979-10-12 1980-10-10 NEW ESTERS OF AMINOBENZOIC ACID

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP54132259A JPS5938960B2 (en) 1979-10-12 1979-10-12 Aminobenzoic acid ester derivatives and pharmaceuticals containing the derivatives

Publications (2)

Publication Number Publication Date
JPS5655397A true JPS5655397A (en) 1981-05-15
JPS5938960B2 JPS5938960B2 (en) 1984-09-20

Family

ID=15077085

Family Applications (1)

Application Number Title Priority Date Filing Date
JP54132259A Expired JPS5938960B2 (en) 1979-10-12 1979-10-12 Aminobenzoic acid ester derivatives and pharmaceuticals containing the derivatives

Country Status (4)

Country Link
JP (1) JPS5938960B2 (en)
BE (1) BE885631A (en)
DE (1) DE3038304C2 (en)
GB (1) GB2060636B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103864638A (en) * 2012-12-14 2014-06-18 沈阳药科大学 Benzoic acid compound, and preparation method and application thereof

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3172379D1 (en) * 1980-12-09 1985-10-24 Seikagaku Kogyo Co Ltd D-xylopyranoside series compounds and therapeutical compositions containing same
HU203896B (en) * 1988-10-26 1991-10-28 Biogal Gyogyszergyar Process for producing glycosides of aromatic amines
AU2001241168B2 (en) * 2000-03-17 2005-06-16 Ajinomoto Co., Inc. Drugs for complications of diabetes and neuropathy and utilization thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103864638A (en) * 2012-12-14 2014-06-18 沈阳药科大学 Benzoic acid compound, and preparation method and application thereof

Also Published As

Publication number Publication date
JPS5938960B2 (en) 1984-09-20
GB2060636A (en) 1981-05-07
DE3038304C2 (en) 1985-08-08
DE3038304A1 (en) 1981-04-23
BE885631A (en) 1981-04-10
GB2060636B (en) 1984-01-11

Similar Documents

Publication Publication Date Title
DE2904552C2 (en) 2,6-Dimethyl-4- (3'-nitrophenyl) -1,4-dihydropyridine-3,5-dicarboxylic acid 3- (1-benzylpyrrolidin-3-yl) ester-5-lower alkyl ester
CA2312898A1 (en) Long acting injectable formulations containing hydrogenated castor oil
CA2015475A1 (en) Treating agent for osteoarthritis
WO1993014767A3 (en) Pharmaceutical preparation based on rhamnolipid against dermatological diseases, e.g. papilloma virus infections
IE780098L (en) Safeguarded toxic chemical compositions containing an¹emetic
JPS5655397A (en) Aminobenzoic acid ester derivative, and physiologically active agent containing said derivative
WO1993017691A3 (en) Pharmaceutical compositions containing monosialoganglioside gm1 or a derivative thereof suitable for the treatment of parkinson's disease
IT1115155B (en) PHARMACEUTICAL PREPARATION CONTAINING A DERIVED ORTHO-AMINOBENZOIC ACID AS ACTIVE INGREDIENT
WO2001017955A3 (en) Hydroxyacetamidobenzenesulphonamide derivatives
JPS5655396A (en) P-aminobenzoic acid derivative, and physiologically active agent containing said derivative
JPS5536403A (en) Preparation of 1-benzazonine derivative
IE781858L (en) N-methylene thienamycin derivatives
JPS5668612A (en) Novel antiallergic agent
KR890009919A (en) 4-heteroaryl-1,3-benzodiazepine and 2-substituted-α- (heteroaryl) benzeneethanamine, methods of preparation and use thereof as medicaments
JPS54154729A (en) Aminobenzoic acid derivative and drug preparation containing the same
EP0124252A3 (en) Double ester of 16beta-ethylestran-17beta-ol derivatives
JPS57114522A (en) Hypotensive agent containing aminobenzoic acid derivative
JPS57136519A (en) Antidiabetic containing aminobenzoic acid derivative
JPS57114521A (en) Antidiabetic agent containing aminobenzoic acid derivative
JPS57140717A (en) Antidiabetic agent containing o- or m-aminobenzoic acid derivative
JPS5634625A (en) Antitumorigenic agent
JPS57140720A (en) Antitumor agent containing o- or m-aminobenzoic acid derivative
JPS57140777A (en) Preparation of piperazine derivative
JPS57140721A (en) Antipyretic and analgesic agent containing o- or m-aminobenzoic acid derivative
JPS57140719A (en) Antiarteriosclerotic agent containing o- or m- aminobenzoic acid derivative